• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
#

Eli Lilly

: 82
Forecasts for the expected size of the global market for obesity treatments have dropped about 30% to $100 billion by 2030, Noble Capital Markets writes / Photo: Shutterstock.com
Small Caps·27.03.2026 14:48
The obesity therapy market is changing. What smid-cap investors should know.
  • HIMS
  • NVO
  • LLY
  • LFMD
Brent crude oil rose in price by more than 3% at trading on March 17 / Photo: Shutterstock.com/Matt Gush
News·18.03.2026 01:14
Oil rose in price, but US stocks rose for the second straight day: results of the 18th day of the war
  • DAL
  • AAL
  • LLY
Pharmaceutical giant Eli Lilly sagged 1.1% in trading on March 17. Photo: Jonathan Weiss/Shutterstock
News·17.03.2026 22:54
Eli Lilly received a rare "sell" recommendation from analysts. Shares fell by 6%
  • LLY
  • NVO
Pharma is the most defensive sector amid conflict in the Middle East - UBS/Photo: shutterstock.com/Jonathan Weiss
News·07.03.2026 04:15
'Most defensive sector': UBS names stocks that can 'safely survive war'
  • LLY
  • MRK
According to three investment banks Eli Lilly could emerge as the leader in the weight loss drug race / Photo: Tada Image / Shutterstock.com
News·26.02.2026 09:30
Three investment banks named Eli Lilly as the leader in the weight loss drug race
  • LLY
  • NVO
The failure of Novo Nordisks experimental drug trial collapsed the companys shares and pulled Danish markets / Photo: Tada Images / Shutterstock
News·23.02.2026 21:54
Novo's failure to test a weight loss drug has sparked a sell-off in the Danish market
  • NVO
  • NOVO-B.CO
  • LLY
A Motley Fool analyst says Viking is the under-the-radar GLP-1 contender that growth hunters cant ignore / Photo: Facebook / Nasdaq
Small Caps·11.02.2026 18:08
Motley Fool calls Viking the GLP‑1 drugmaker growth-hunting investors 'can't ignore'
  • VKTX
  • NVO
  • LLY
Novo Nordisk shares fell after Him&Hers announced the launch of its weight loss pill/ Photo: x.com/novonordisk
News·06.02.2026 09:00
Novo Nordisk and Eli Lilly shares plummet: the weight-loss pill will have a $49 copy
  • NVO
  • LLY
  • HIMS
JOLTS data for December, postponed due to the shutdown, will be released today to clarify the dynamics of labor demand / Photo: Unsplash/sol
News·05.02.2026 15:45
Morning in New York: statistics and corporate news will determine the trading vector
  • GOOGL
  • QCOM
  • SNAP
  • LLY
  • +1
Eli Lilly forecasts revenue growth of 23-27% in 2026 / Photo: Tada Images/Shutterstock.com
News·04.02.2026 19:46
Eli Lilly predicted revenue growth of 27% in 2026. Why is it better than Novo Nordisk?
  • LLY
  • NVO
  • NOVO-B.CO
Novos revenue could fall 5-13% in 2026/ Photo: Kittyfly/ Shutterstock.com
News·04.02.2026 03:56
Novo Nordisk warned of a drop in revenue in 2026. Quotes collapsed by 15%
  • NVO
  • LLY
Alphabet, Googles parent company, will release its quarterly report this week / Photo: Shutterstock.com
News·02.02.2026 10:19
Google and Amazon earnings, US employment: what investors need to know this week
  • GOOGL
  • AMZN
  • PLTR
Load more
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026